Cutiss
Last verified 2026-05-06. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $61.6Mattributed |
|---|---|
| Latest round | series-c, $61.6M, 2025-09-01attributed |
| Founded | 2017 |
| Headquarters | Zurich |
| Industry | bio |
| Stage | series-b+ |
| Website | cutiss.swiss |
Cutiss is a biotech developing personalized, lab-grown human skin grafts produced through automated manufacturing. Its denovoSkin therapy is aimed at patients needing skin surgery, including severe burns and reconstructive cases. Its differentiator is a patented, fully closed, end-to-end automation platform that enables decentralized, scalable production of living personalized skin.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-09-01 | series-c | $61.6M | undisclosed |
Detected tech stack
WordPress 6.9.4, Apache HTTP Server, Astra 4.13.1, reCAPTCHA, Google Analytics, Google Sign-in, Google Tag Manager, jQuery Migrate 3.4.1, Elementor 4.0.7, parallax.js 1.0, particles.js, DoubleClick Floodlight
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series C, $61.6M | attributed | crunchbase named as publisher. No document URL on file. |
| Total raised $61.6M | attributed | crunchbase named as publisher. No document URL on file. |
| Company existence | self-reported | cutiss.swiss, read 2026-05-06 |
| Description | self-reported | cutiss.swiss, read 2026-05-06 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.